TheEdgeResearch
Home / Stocks / ADVT

Advantis Corp. (ADVT)

OTC Healthcare Medical - Pharmaceuticals
$0.00 ▲ +0.00%
Market Cap
$9,785
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
-3.97
52-Wk Range
0.000001-0.00001
CEO
Darren Cherry
Country
US
Currency
USD

Advantis Corp. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Newport Beach, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $9,785. On trailing twelve-month figures it carries a trailing P/E of -0.41, a net margin of -2.9%. Its beta of -3.97 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.41
Price / Sales
0.01
Price / Book
-0.01
EV / EBITDA
-18.69
Gross margin
92.3%
Operating margin
-2.8%
Net margin
-2.9%
Return on equity
Debt / equity
-0.56
Current ratio
0.49
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
5
IPO date
1996-07-22
Headquarters
Newport Beach, CA, US
About Advantis Corp.

Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions. Advantis Corp. was formerly known as Ramoil Management, Ltd. and changed its name to Advantis Corp. in December 2015. Advantis Corp. is based in Newport Beach, California.

Comparable companies

Advantis Corp. is most often compared with the following Healthcare names:

BBBTCANLEAPHGCANGREHNVOSOMHEREZNFWRHLFXTXXF
More research on ADVT
ADVT technical analysis ADVT TheEdge Score Compare against peers
Open full interactive analysis & DCF →